Sex, racial, and ethnic diversity in clinical trials
Clinical and Translational Science · 2023-06 · 16 (6) · 937-945
DOI: 10.1111/cts.13513 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical and Translational Science, online erschienen am 24.03.2023. Verfasst von Julie Bøttern und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Ethnicity, Minority Groups. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Diverse representation in clinical trials is crucial to understand the efficacy and safety of drugs in minority groups. This review aims to (1) describe research participants' sex, racial, and ethnic diversity in clinical drug trials and (2) describe the sex distribution of researchers conducting the research. We reviewed all clinical drug trials published in the journals “Clinical Pharmacology and Therapeutics” and “Clinical and Translational Science” in 2000–2001 and 2020–2021 and analyzed the research participants' and researchers' demographics. We compared the race of the research participants with the concurrent race diversity of the reference population in the countries where the research was conducted. We identified 281 articles with 17,639 research participants. Approximately one‐third of the research participants were women in both 2000–2001 and 2020–2021. The representation from racial minorities of Black and Asian people increased from 2000–2001 to 2020–2021, but Asian and Native American people are still under‐represented in clinical drug trials today. The proportion of female authors increased, but female authors still made up less than 40% of the total number of authors in 2020–2021. In conclusion, men are still over‐represented in clinical pharmacology research, and some races are still vastly under‐represented. Furthermore, although the proportion of female authors increased with time, they are still under‐represented as first and last authors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- Department of Pharmacology, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Tore Bjerregaard Stage, Ann-Cathrine Dalgård Dunvald
Zitieren
APA
Bøttern, J., Stage, T. B., & Dunvald, A. D. (2023). Sex, racial, and ethnic diversity in clinical trials. Clinical and Translational Science, 16(6), 937-945. https://doi.org/10.1111/cts.13513
Vancouver
Bøttern J, Stage TB, Dunvald AD. Sex, racial, and ethnic diversity in clinical trials. Clinical and Translational Science. 2023;16(6):937-945. doi:10.1111/cts.13513
BibTeX
@article{Bttern2023,
author = {Bøttern, Julie and Stage, Tore Bjerregaard and Dunvald, Ann-Cathrine Dalgård},
title = {Sex, racial, and ethnic diversity in clinical trials},
journal = {Clinical and Translational Science},
year = {2023},
volume = {16},
number = {6},
pages = {937--945},
doi = {10.1111/cts.13513}
}
EUVIMED